Xtrackers MSCI Global SDG 3 Good Health UCITS ETF Fund (SWX:XDG3)
27.25
+0.01 (0.04%)
At close: Jul 14, 2025, 5:20 PM CET
SWX:XDG3 Holdings Information
SWX:XDG3 is an equity ETF with a total of 111 individual holdings. The top holdings are Eli Lilly and Company stock at 4.66%, Novartis AG at 4.64%, Gilead Sciences at 4.54%, Stryker at 4.54%, and Abbott Laboratories at 4.49%.
Total Holdings
111
Top 10 Percentage
45.12%
Asset Class
Equity
ETF Category
Health Care
Assets
28.11M
PE Ratio
20.01
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | LLY | Eli Lilly and Company | 4.66% |
2 | SWX: NOVN | Novartis AG | 4.64% |
3 | GILD | Gilead Sciences, Inc. | 4.54% |
4 | SYK | Stryker Corporation | 4.54% |
5 | ABT | Abbott Laboratories | 4.49% |
6 | ABBV | AbbVie Inc. | 4.48% |
7 | CPH: NOVO.B | Novo Nordisk A/S | 4.48% |
8 | DHR | Danaher Corporation | 4.46% |
9 | MRK | Merck & Co., Inc. | 4.43% |
10 | VRTX | Vertex Pharmaceuticals Incorporated | 4.39% |
11 | TMO | Thermo Fisher Scientific Inc. | 4.38% |
12 | BSX | Boston Scientific Corporation | 4.26% |
13 | AMGN | Amgen Inc. | 3.89% |
14 | BMY | Bristol-Myers Squibb Company | 3.43% |
15 | EPA: SAN | Sanofi | 2.85% |
16 | PFE | Pfizer Inc. | 2.78% |
17 | MDT | Medtronic plc | 2.20% |
18 | LON: GSK | GSK plc | 2.08% |
19 | ASX: CSL | CSL Limited | 1.91% |
20 | REGN | Regeneron Pharmaceuticals, Inc. | 1.88% |
21 | EW | Edwards Lifesciences Corporation | 1.49% |
22 | KMB | Kimberly-Clark Corporation | 1.35% |
23 | DXCM | DexCom, Inc. | 1.32% |
24 | GEHC | GE HealthCare Technologies Inc. | 1.30% |
25 | A | Agilent Technologies, Inc. | 1.29% |
As of Jun 30, 2025